Successful outcome of ganciclovir-resistant cytomegalovirus infection in organ transplant recipients after conversion to mTOR inhibitors
Author:
Publisher
Frontiers Media SA
Subject
Transplantation
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1432-2277.2012.01489.x/fullpdf
Reference16 articles.
1. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation;Kotton;Transplantation,2010
2. GESITRA-SEIMC/REIPI recommendations for the management of cytomegalovirus infection in solid-organ transplant recipients;de la Torre-Cisneros;Enferm Infecc Microbiol Clin,2011
3. Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants;Limaye;Lancet,2000
4. Emergence of drug-resistant cytomegalovirus in the era of valganciclovir prophylaxis: therapeutic implications and outcomes;Eid;Clin Transpl,2008
5. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients;Eisen;N Engl J Med,2003
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Management of resistant and refractory cytomegalovirus infections after transplantation;Expert Review of Anti-infective Therapy;2024-09-05
2. Cytomegalovirus Treatment in Solid Organ Transplantation: An Update on Current Approaches;Annals of Pharmacotherapy;2024-03-19
3. The incidence of cytomegalovirus and BK polyomavirus infections in kidney transplant patients receiving mTOR inhibitors: A systematic review and meta‐analysis;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2023-04-10
4. American Society for Transplantation and Cellular Therapy Series: #4 - Cytomegalovirus treatment and management of resistant or refractory infections after hematopoietic cell transplantation;Transplantation and Cellular Therapy;2021-12
5. Case Report: Management of a Multidrug-Resistant CMV-Strain in a Renal Transplant Recipient by High-Dose CMV-Specific Immunoglobulins, Modulation in Immunosuppression, and Induction of CMV-Specific Cellular Immunity;Frontiers in Immunology;2021-01-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3